Principal Investigator
Camillo Ricordi
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20200966
Clinical Trial Summary
A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects With Type 1 Diabetes Mellitus and Impaired Hypoglycemic Awareness and Severe Hypoglycemia
Phase
Phase I/II
Funding Agency/Sponsor
Industry
Disease
Other